We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+172.01%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$116M
AUM Growth
+$73.6M
Cap. Flow
+$6.49K
Cap. Flow %
0.01%
Top 10 Hldgs %
100%
Holding
1
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$6.49K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.58B
$116M 100%
5,618,861
+437
+0% +$6.49K

Similar funds

Summer Road's Q4 2020 Portfolio in Review

As of Q4 2020, Summer Road held 1 position worth $116M, up 172% from $42.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road added most to Ocular Therapeutix in Q4 2020, an estimated $6.49K increase.
  • Summer Road's ten largest holdings make up 100% of its $116M portfolio in Q4 2020.
  • Summer Road opened 0 new positions and closed 0 in Q4 2020.
  • Summer Road's portfolio value rose 172% quarter-over-quarter to $116M.

Based on Summer Road's 13F filing for Q4 2020, filed 16 Feb 2021.